Literature DB >> 25324123

Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Taku Kambayashi1, Terri M Laufer2.   

Abstract

Dendritic cells, macrophages and B cells are regarded as the classical antigen-presenting cells of the immune system. However, in recent years, there has been a rapid increase in the number of cell types that are suggested to present antigens on MHC class II molecules to CD4(+) T cells. In this Review, we describe the key characteristics that define an antigen-presenting cell by examining the functions of dendritic cells. We then examine the functions of the haematopoietic cells and non-haematopoietic cells that can express MHC class II molecules and that have been suggested to represent 'atypical' antigen-presenting cells. We consider whether any of these cell populations can prime naive CD4(+) T cells and, if not, question the effects that they do have on the development of immune responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25324123     DOI: 10.1038/nri3754

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  158 in total

1.  Th2 immunity: a step closer to completion.

Authors:  Booki Min
Journal:  Immunol Cell Biol       Date:  2010 Mar-Apr       Impact factor: 5.126

2.  Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma.

Authors:  Tomonobu Ito; Chiharu Nishiyama; Nobuhiro Nakano; Makoto Nishiyama; Yoshihiko Usui; Kazuyoshi Takeda; Shunsuke Kanada; Kanako Fukuyama; Hisaya Akiba; Tomoko Tokura; Mutsuko Hara; Ryoji Tsuboi; Hideoki Ogawa; Ko Okumura
Journal:  Int Immunol       Date:  2009-06-05       Impact factor: 4.823

3.  Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR.

Authors:  T T Hansel; J B Braunstein; C Walker; K Blaser; P L Bruijnzeel; J C Virchow; C Virchow
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

4.  Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions.

Authors:  Anne L Fletcher; Veronika Lukacs-Kornek; Erika D Reynoso; Sophie E Pinner; Angelique Bellemare-Pelletier; Mark S Curry; Ai-Ris Collier; Richard L Boyd; Shannon J Turley
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

5.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

Authors:  Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

6.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens.

Authors:  R L Evans; T J Faldetta; R E Humphreys; D M Pratt; E J Yunis; S F Schlossman
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

Review 7.  Alveolar epithelial type II cell: defender of the alveolus revisited.

Authors:  H Fehrenbach
Journal:  Respir Res       Date:  2001-01-15

8.  Basophils are required for the induction of Th2 immunity to haptens and peptide antigens.

Authors:  Atsushi Otsuka; Saeko Nakajima; Masato Kubo; Gyohei Egawa; Tetsuya Honda; Akihiko Kitoh; Takashi Nomura; Sho Hanakawa; Catharina Sagita Moniaga; Bongju Kim; Satoshi Matsuoka; Takeshi Watanabe; Yoshiki Miyachi; Kenji Kabashima
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo.

Authors:  P D Collins; S Marleau; D A Griffiths-Johnson; P J Jose; T J Williams
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

10.  Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite.

Authors:  Booki Min; Melanie Prout; Jane Hu-Li; Jinfang Zhu; Dragana Jankovic; Ellen S Morgan; Joseph F Urban; Ann M Dvorak; Fred D Finkelman; Graham LeGros; William E Paul
Journal:  J Exp Med       Date:  2004-08-16       Impact factor: 14.307

View more
  163 in total

Review 1.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 2.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

3.  HLA-DR Class II expression on myeloid and lymphoid cells in relation to HLA-DRB1 as a genetic risk factor for visceral leishmaniasis.

Authors:  Bhawana Singh; Michaela Fakiola; Medhavi Sudarshan; Joyce Oommen; Siddharth Sankar Singh; Shyam Sundar; Jenefer M Blackwell
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

4.  Neutrophils acquire antigen-presenting cell features after phagocytosis of IgG-opsonized erythrocytes.

Authors:  Sanne M Meinderts; Gabriella Baker; Stan van Wijk; Boukje M Beuger; Judy Geissler; Machiel H Jansen; Anno Saris; Anja Ten Brinke; Taco W Kuijpers; Timo K van den Berg; Robin van Bruggen
Journal:  Blood Adv       Date:  2019-06-11

5.  HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer.

Authors:  Bianca Cioni; Ekaterina S Jordanova; Erik Hooijberg; Rianne van der Linden; Renee X de Menezes; Katherine Tan; Stefan Willems; Joris B W Elbers; Annegien Broeks; Andries M Bergman; Charlotte L Zuur; Jan Paul de Boer
Journal:  Head Neck       Date:  2018-12-14       Impact factor: 3.147

Review 6.  Professional and 'Amateur' Antigen-Presenting Cells In Type 2 Immunity.

Authors:  Martijn J Schuijs; Hamida Hammad; Bart N Lambrecht
Journal:  Trends Immunol       Date:  2018-11-27       Impact factor: 16.687

7.  Antigen-Presenting Cells: Potential of Proven und New Players in Immune Therapies.

Authors:  Britta Eiz-Vesper; Helga Maria Schmetzer
Journal:  Transfus Med Hemother       Date:  2020-11-10       Impact factor: 3.747

8.  TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity.

Authors:  Osman N Yogurtcu; Zuben E Sauna; Joseph R McGill; Million A Tegenge; Hong Yang
Journal:  AAPS J       Date:  2019-08-02       Impact factor: 4.009

9.  MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells.

Authors:  Julia Merkenschlager; Urszula Eksmond; Luca Danelli; Jan Attig; George R Young; Carla Nowosad; Pavel Tolar; George Kassiotis
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

10.  MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.

Authors:  Motoko Koyama; Pamela Mukhopadhyay; Iona S Schuster; Andrea S Henden; Jan Hülsdünker; Antiopi Varelias; Marie Vetizou; Rachel D Kuns; Renee J Robb; Ping Zhang; Bruce R Blazar; Ranjeny Thomas; Jakob Begun; Nicola Waddell; Giorgio Trinchieri; Robert Zeiser; Andrew D Clouston; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Immunity       Date:  2019-09-18       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.